Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12623000829617
ACTRN12623000829617
Not yet recruiting
未知

Implementing a Nurse-Enabled, Shared-Care Model to Address Unmet Needs of People with Neuroendocrine Tumours – a randomised-controlled type II hybrid effectiveness-implementation trial (the AUS-NET trial)

Caring Futures Institute, College of Nursing and Health Sciences, Flinders University0 sites510 target enrollmentAugust 2, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionseuroendocrine NeoplasmsNeuroendocrine NeoplasmsCancer - Neuroendocrine tumour (NET)Public Health - Health service research

Overview

Phase
未知
Intervention
Not specified
Conditions
euroendocrine Neoplasms
Sponsor
Caring Futures Institute, College of Nursing and Health Sciences, Flinders University
Enrollment
510
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 2, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Caring Futures Institute, College of Nursing and Health Sciences, Flinders University

Eligibility Criteria

Inclusion Criteria

  • •Patients aged 18 years of age or older
  • •\- histologically confirmed neuroendocrine neoplasm (NENs) as per the 2017 World Health Organisation Classification:
  • •oWell differentiated neuroendocrine neoplasms: Neuroendocrine tumours (NET) (Grades 1\-3\)
  • •oPoorly differentiated neuroendocrine neoplasms: Neuroendocrine carcinoma (NEC)
  • •\- can identify, or be willing to identify a usual General Practitioner or General Practice
  • •\- ambulatory with ECOG performance status of 0\-2
  • •\- have access to a telephone or telehealth via smartphone, electronic tablet, personal computer, or equivalent, and
  • •\- be able to speak and read English.

Exclusion Criteria

  • •\- Patients diagnosed with pheochromocytoma or paraganglioma
  • •\- Patients with small cell lung NEC or large cell lung NEC
  • •\- Patients with severe mental, cognitive, or physical conditions or other circumstance that would limit their ability to participate at the discretion of the treating clinician
  • •\- Patients judged to have \<6 months of life expectancy at the discretion of the treating clinician
  • •\- Patients judged to be unable to provide consent at the discretion of the treating clinician

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Implementing a nurse-coordinated, integrated, shared-care model involving specialists and general practitioners in breast cancer post-treatment follow-up: a Phase II randomised controlled trialBreast CancerCancer - Breast
ACTRN12619001594112Professor Raymond Chan63
Recruiting
Not Applicable
Implementation of an integrated care programme to avoid fragility fractures in older adults in 18 Bavarian hospitals - study protocol for the cluster-randomised controlled fracture liaison service FLS-CAREM81.9S72.0Osteoporosis, unspecifiedFracture of neck of femur
DRKS00022237Klinik für Allgemeine- Unfall und Wiederherstellungschirurgie1,216
Recruiting
Not Applicable
Development of a nursing care program that promotes oral intake for post-stroke patients
JPRN-UMIN000051215niversity of Hyogo30
Active, not recruiting
Not Applicable
Co-designing a technology-informed pathway in primary care to improve the kidney health of people living with heart failureCardiovascular, renal and urogenitalCirculatory System
ISRCTN75284771niversity of Liverpool732
Not yet recruiting
Not Applicable
Development of nursing care program to sustain the patients with recurrent lung cancer using &quot;Hope-Design Note&quot;patients with recurrent lung cancer
JPRN-UMIN000028219Tokyo Medical and Dental University5